Movano Inc. (MOVE)
USD 0.87
(9.86%)
USD 0.87
(9.86%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 9.42 Million USD | -28.86% |
| 2022 | 13.24 Million USD | -63.48% |
| 2021 | 36.26 Million USD | 412.0% |
| 2020 | 7.08 Million USD | 44.94% |
| 2019 | 4.88 Million USD | 43.52% |
| 2018 | 3.4 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 20.82 Million USD | 305.57% |
| 2024 Q1 | 5.13 Million USD | -45.49% |
| 2023 Q2 | 17.57 Million USD | 4.89% |
| 2023 FY | 9.42 Million USD | -28.86% |
| 2023 Q4 | 9.42 Million USD | -11.06% |
| 2023 Q3 | 10.59 Million USD | -39.72% |
| 2023 Q1 | 16.75 Million USD | 26.51% |
| 2022 Q1 | 29.63 Million USD | -18.28% |
| 2022 FY | 13.24 Million USD | -63.48% |
| 2022 Q4 | 13.24 Million USD | -31.92% |
| 2022 Q3 | 19.45 Million USD | -20.25% |
| 2022 Q2 | 24.39 Million USD | -17.7% |
| 2021 Q3 | 41.57 Million USD | -7.89% |
| 2021 FY | 36.26 Million USD | 412.0% |
| 2021 Q4 | 36.26 Million USD | -12.76% |
| 2021 Q2 | 45.13 Million USD | -8.66% |
| 2021 Q1 | 49.41 Million USD | 597.6% |
| 2020 Q4 | 7.08 Million USD | -18.96% |
| 2020 Q3 | 8.74 Million USD | 0.0% |
| 2020 Q1 | - USD | -100.0% |
| 2020 FY | 7.08 Million USD | 44.94% |
| 2019 Q4 | 4.88 Million USD | 0.0% |
| 2019 FY | 4.88 Million USD | 43.52% |
| 2018 FY | 3.4 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| PetVivo Holdings, Inc. | 3.11 Million USD | -202.415% |
| Talis Biomedical Corporation | 98.34 Million USD | 90.42% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -22.478% |
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 69.964% |
| Bioventus Inc. | 810.91 Million USD | 98.838% |
| Cerus Corporation | 197.74 Million USD | 95.236% |
| CVRx, Inc. | 115.22 Million USD | 91.824% |
| electroCore, Inc. | 16.38 Million USD | 42.509% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 83.94% |
| OrthoPediatrics Corp. | 449.58 Million USD | 97.905% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 65.453% |
| Spectral AI, Inc. | 10.69 Million USD | 11.887% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | 43.175% |
| BrainsWay Ltd. | 62.97 Million USD | 85.039% |
| Envoy Medical, Inc. | 7.64 Million USD | -23.312% |
| MaxCyte, Inc. | 268.27 Million USD | 96.488% |
| NanoVibronix, Inc. | 6.67 Million USD | -41.16% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 95.691% |
| Nexalin Technology, Inc. | 3.63 Million USD | -159.395% |
| Orthofix Medical Inc. | 925.31 Million USD | 98.982% |
| Inogen, Inc. | 326.19 Million USD | 97.112% |
| IceCure Medical Ltd | 16.41 Million USD | 42.59% |
| PAVmed Inc | 33.11 Million USD | 71.554% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 59.737% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 93.433% |
| RxSight, Inc. | 182.55 Million USD | 94.839% |
| Sight Sciences, Inc. | 166.65 Million USD | 94.347% |
| SI-BONE, Inc. | 230.42 Million USD | 95.911% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -16.347% |
| TELA Bio, Inc. | 78.04 Million USD | 87.929% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 63.378% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 96.26% |
| Venus Concept Inc. | 93.65 Million USD | 89.941% |
| Acutus Medical, Inc. | 53.96 Million USD | 82.541% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | 12.199% |
| LivaNova PLC | 2.42 Billion USD | 99.612% |
| 908 Devices Inc. | 202.98 Million USD | 95.359% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 98.83% |
| Nemaura Medical Inc. | 14.56 Million USD | 35.31% |
| NeuroPace, Inc. | 107.65 Million USD | 91.249% |
| LENSAR, Inc. | 69.58 Million USD | 86.461% |
| Apyx Medical Corporation | 79.24 Million USD | 88.111% |
| Cutera, Inc. | 346.29 Million USD | 97.279% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 77.578% |
| BioSig Technologies, Inc. | 1.79 Million USD | -423.971% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 96.519% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 77.917% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.751% |
| Axonics, Inc. | 719.92 Million USD | 98.691% |
| Outset Medical, Inc. | 313.8 Million USD | 96.998% |
| IRIDEX Corporation | 34.43 Million USD | 72.642% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 97.672% |
| IRadimed Corporation | 92.15 Million USD | 89.777% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -79.311% |
| INVO Bioscience, Inc. | 20.88 Million USD | 54.897% |
| Telesis Bio, Inc. | 70.41 Million USD | 86.62% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 93.887% |
| Varex Imaging Corporation | 1.24 Billion USD | 99.246% |
| Quipt Home Medical Corp. | 247.4 Million USD | 96.192% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -1.192% |
| Pulmonx Corporation | 178.95 Million USD | 94.735% |
| Dynatronics Corporation | 25.94 Million USD | 63.682% |
| Modular Medical, Inc. | 13.8 Million USD | 31.766% |
| ReShape Lifesciences Inc. | 10.72 Million USD | 12.175% |
| Semler Scientific, Inc. | 78.06 Million USD | 87.932% |
| InMode Ltd. | 863.28 Million USD | 98.909% |
| Bruker Corporation | 4.24 Billion USD | 99.778% |
| Cytosorbents Corporation | 53.26 Million USD | 82.312% |
| DexCom, Inc. | 6.26 Billion USD | 99.85% |
| Align Technology, Inc. | 6.08 Billion USD | 99.845% |
| Viveve Medical, Inc. | 25.91 Million USD | 63.644% |
| ZimVie Inc. | 1.2 Billion USD | 99.218% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 98.107% |
| Nexalin Technology, Inc. | 3.63 Million USD | -159.395% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 83.94% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 99.011% |
| Profound Medical Corp. | 43.68 Million USD | 78.435% |
| Insulet Corporation | 2.58 Billion USD | 99.636% |
| enVVeno Medical Corporation | 48.63 Million USD | 80.629% |
| Surmodics, Inc. | 185.73 Million USD | 94.928% |
| iCAD, Inc. | 41.41 Million USD | 77.254% |
| Nuwellis, Inc. | 9.77 Million USD | 3.572% |
| Biotricity, Inc. | 5.94 Million USD | -58.533% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 97.825% |
| Aethlon Medical, Inc. | 8.24 Million USD | -14.25% |
| InspireMD, Inc. | 47.64 Million USD | 80.226% |
| PAVmed Inc. | 33.11 Million USD | 71.554% |
| BIOLASE, Inc. | 35.1 Million USD | 73.16% |
| Beyond Air, Inc. | 56.96 Million USD | 83.461% |
| FONAR Corporation | 214.24 Million USD | 95.603% |
| AxoGen, Inc. | 196.82 Million USD | 95.214% |
| Vivani Medical, Inc. | 45.79 Million USD | 79.429% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 96.653% |
| Inari Medical, Inc. | 674.23 Million USD | 98.603% |
| UFP Technologies, Inc. | 404.13 Million USD | 97.669% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | 0.864% |
| Tenon Medical, Inc. | 6.34 Million USD | -48.479% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -0.149% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 90.911% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.796% |
| Sintx Technologies, Inc. | 15.36 Million USD | 38.685% |
| Quanterix Corporation | 425.01 Million USD | 97.783% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -1.192% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 82.465% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.46% |
| TransMedics Group, Inc. | 706.04 Million USD | 98.666% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 85.091% |
| NeuroMetrix, Inc. | 21.42 Million USD | 56.027% |
| Hyperfine, Inc. | 94.19 Million USD | 89.999% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 96.493% |
| Biomerica, Inc. | 9.25 Million USD | -1.805% |
| Bone Biologics Corporation | 3.73 Million USD | -152.049% |
| AVITA Medical, Inc. | 144.33 Million USD | 93.473% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -93.508% |
| Silk Road Medical, Inc | 265.3 Million USD | 96.449% |